Obermeyer Wood Investment Counsel, Lllp Bristol Myers Squibb CO Transaction History
Obermeyer Wood Investment Counsel, Lllp
- $1.86 Billion
- Q4 2024
A detailed history of Obermeyer Wood Investment Counsel, Lllp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Obermeyer Wood Investment Counsel, Lllp holds 10,186 shares of BMY stock, worth $611,974. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,186
Previous 10,187
0.01%
Holding current value
$611,974
Previous $527,000
9.3%
% of portfolio
0.03%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,764Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.53 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.77 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.72 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...